Article
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review
8 Dec 2023
Abstract excerpt
The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatment. Current therapeutic options in chronic HBV, based on interferons and/or nucleos(t)ide analogs, suppress the virus replication but do not eliminate the pathogen and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
